Christopher Bunka
Chief Executive Officer, Director at Lexaria Bioscience Corp. (LEXX)
Christopher Bunka has filed 10 insider reports with the SEC since September 2021, as chief Executive Officer and director at Lexaria Bioscience Corp. (LEXX). Christopher Bunka made no open-market purchases or sales in the last 12 months. The latest filing, on March 18, 2026, reports gift at Lexaria Bioscience Corp. (LEXX).
- Filings
- 10
- Companies
- 1
- Bought on market
- $104K
- Sold on market
- None
Companies where Christopher Bunka is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officer, Director | 273,543 | $104K | $1.57 | $4.03+157% | Mar 18, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Mar 17, 2026LEXXSEC Form 4 filed by Bunka ChristopherForm 4Gift
- Jul 30, 2025+$25.2KLEXXDirector Bunka Christopher bought $25,241 worth of shares (27,500 units at $0.92)Form 4Open-market purchase
- May 15, 2025LEXXSEC Form 4 filed by Director Bunka ChristopherForm 4Grant or award
- Jan 7, 2025LEXXDirector Bunka Christopher was granted 100,000 units of Restricted Stock Award, increasing direct ownership by 37% to 373,543 unitsForm 4Grant or award
- Apr 26, 2024LEXXSEC Form 4 filed by Bunka ChristopherForm 4Grant or award
- Oct 26, 2023LEXXSEC Form 4 filed by Bunka ChristopherForm 4Grant or award
- Oct 13, 2022+$78.4KLEXXSEC Form 4: Bunka Christopher bought $78,397 worth of shares (38,500 units at $2.04) (Amendment)Form 4Open-market purchase
- Oct 13, 2022LEXXSEC Form 4: Bunka Christopher was granted 38,500 sharesForm 4Grant or award
- Aug 29, 2022LEXXSEC Form 4 filed by Bunka ChristopherForm 4Grant or award
- Sep 1, 2021LEXXSEC Form 4 filed by Bunka ChristopherForm 4Grant or award
Compare Christopher Bunka with
- Christopher Bunka vs William Edward McKechnie1 shared
- Christopher Bunka vs John Martin Docherty1 shared
- Christopher Bunka vs Vanessa Carle1 shared
- Christopher Bunka vs Richard Christopher1 shared
- Christopher Bunka vs Michael Elliot Shankman1 shared
- Christopher Bunka vs Baljinder Bhullar1 shared
Other insiders at the same companies
- William Edward McKechnieLEXX
- John Martin DochertyLEXX
- Vanessa CarleLEXX
- Richard ChristopherLEXX
- Michael Elliot ShankmanLEXX
- Baljinder BhullarLEXX
- Nicholas W BaxterLEXX
- Albert L Reese JrLEXX
Questions about Christopher Bunka
- What is Christopher Bunka's role at Lexaria Bioscience Corp.?
- Christopher Bunka reports to the SEC as chief Executive Officer and director at Lexaria Bioscience Corp. (LEXX), according to the latest filing on March 18, 2026.
- How many shares does Christopher Bunka own?
- After the latest filing that states it, Christopher Bunka directly owned 273,543 shares of Lexaria Bioscience Corp. (LEXX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Christopher Bunka bought or sold stock recently?
- The most recent open-market purchase was on July 30, 2025: bought 27,500 shares of Lexaria Bioscience Corp. (LEXX) for $25.2K at an average of $0.92.
- How do I get alerts when Christopher Bunka files?
- Follow Christopher Bunka on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Christopher Bunka (SEC CIK 0001103780). Totals count each trade once, skipping amendments whose original is on file, from Sep 2, 2021 on. View on SEC EDGAR · Get this as JSON